Europe Blood Glucose Monitoring Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Europe Blood Glucose Monitoring Market segmented by Type (Self-monitoring Blood Glucose, and Continuous Glucose Monitoring), Component (Glucometer Devices, Test Strips, Lancets, Sensors, and Durables), and by Geography.

Market Snapshot

 Europe Blood Glucose Monitoring Market Overview
Study Period: 2018 - 2026
Base Year: 2020
CAGR: >11 %
 Europe Blood Glucose Monitoring Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Europe holds the third-largest market share in the blood glucose monitoring devices market after the Asia Pacific and North America. Europe is expected to generate revenue of more than USD 5 billion by 2025, registering a CAGR of more than 11%. Diabetes prevalence is continually increasing and checking blood glucose levels regularly with glucose monitoring devices is vital for proper diabetes diagnosis and treatment. People who have diabetes (Type-1 and Type-2) can have improved lives by carefully regulating their blood glucose levels. Owing to the increased patient awareness for glucose monitoring devices, Self-Monitoring Blood Glucose (SMBG) users grew by more than 5% in 2019 from the number of users in 2017.

Scope of the Report

The market segmented by type (self-monitoring blood glucose and continuous glucose monitoring), by component (glucometer devices, test strips, lancets, sensors, and durables), and by geography. In the report, Europe segmented into Germany, Spain, Russia, Italy, the United Kingdom, France and the Rest of Europe. The report includes the following aspect:

By Type
Self-monitoring Blood Glucose Devices
By Component (Value and Volume, 2012-2025)
Glucometer Devices
Test Strips
Lancets
Continuous Glucose Monitoring
By Component (Value and Volume, 2012-2025)
Sensors
Durables
By Geography
Europe
France (Value and Volume, 2012-2025)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)
Germany (Value and Volume, 2012-2025)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)
Italy (Value and Volume, 2012-2025)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)
Spain (Value and Volume, 2012-2025)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)
United Kingdom (Value and Volume, 2012-2025)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)
Russia (Value and Volume, 2012-2025)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)
Rest of Europe (Value and Volume, 2012-2025)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)

Report scope can be customized per your requirements. Click here.

Key Market Trends

Test Strips accounted for a major market share in 2019

Currently, in the Europe Blood Glucose Monitoring market, test strips account for more than 53% of the market. Test strips impact the patient's costs more because test strips are a continuous expense whereas glucometer device is single time purchase. Although, the CGM is more advanced patients prefer glucometer because CGM is very expensive as compared to glucometer and cost associated with its consumables. Overall, the demand for the blood glucose test strips is projected to witness significant growth, over the forecast period. The growth of the market studied is expected to be spurred by the rising global diabetic population.

 Europe Blood Glucose Monitoring Market Key Trends

Germany dominated the Europe Blood Glucose Monitoring Market in 2019

Germany held a major share of the market in 2019 and is expected to continue to do so in the coming years. It is estimated that Germany will register a CAGR of over 10% during the forecast period. In Germany, close to 10% of people suffer from diabetes, in which the type-2 diabetic population accounts for 98%. Blood glucose monitoring is widely used in developed countries due to high awareness and better reimbursement policies as compared to the developing countries. The self-blood glucose monitoring market recorded the highest sales in Germany and accounted for approximately 84% of the market studied.

 Europe Blood Glucose Monitoring Market Growth by Region

Competitive Landscape

The glucometer market is highly fragmented; some of the market players who have high market share are Abbott, Roche, and Johnson and Johnson. The Continuous Glucose Monitoring market, on the other hand, is a highly consolidated market, few players hold more than 70% of the market share in the CGM market.

LIST OF TABLES AND FIGURES

 

LIST OF TABLES

1 Europe Blood Glucose Monitoring Market: Revenue in USD million, by Product, 2012 - 2024
2 Europe Blood Glucose Monitoring Market: Revenue in USD million, by Self Monitoring Blood Glucose Market, 2012-2024
3 Europe Blood Glucose Monitoring Market: Revenue in USD million, by Test Strips, by Technology, 2012-2024
4 Europe Blood Glucose Monitoring Market: Revenue in USD million, by Continuous Glucose Monitoring, 2012-2024
5 Europe Blood Glucose Monitoring Market: Revenue in USD million, by Geography, Europe, 2012-2024
6 Europe Blood Glucose Monitoring Market: Revenue in USD million, United Kingdom, by Self Monitoring Blood Glucose Market, 2012-2024
7 Europe Blood Glucose Monitoring Market: Revenue in USD million, United Kingdom, by Continuous Glucose Monitoring, 2012-2024
8 Europe Blood Glucose Monitoring Market: Revenue in USD million, Germany, by Self Monitoring Blood Glucose Market, 2012-2024
9 Europe Blood Glucose Monitoring Market: Revenue in USD million, Germany, by Continuous Glucose Monitoring, 2012-2024
10 Europe Blood Glucose Monitoring Market: Revenue in USD million, France, by Self Monitoring Blood Glucose Market, 2012-2024
11 Europe Blood Glucose Monitoring Market: Revenue in USD million, France, by Continuous Glucose Monitoring, 2012-2024
12 Europe Blood Glucose Monitoring Market: Revenue in USD million, Italy, by Self Monitoring Blood Glucose Market, 2012-2024
13 Europe Blood Glucose Monitoring Market: Revenue in USD million, Italy, by Continuous Glucose Monitoring, 2012-2024
14 Europe Blood Glucose Monitoring Market: Revenue in USD million, Spain, by Self Monitoring Blood Glucose Market, 2012-2024
15 Europe Blood Glucose Monitoring Market: Revenue in USD million, Spain, by Continuous Glucose Monitoring, 2012-2024
16 Europe Blood Glucose Monitoring Market: Revenue in USD million, Russia, by Self Monitoring Blood Glucose Market, 2012-2024
17 Europe Blood Glucose Monitoring Market: Revenue in USD million, Russia, by Continuous Glucose Monitoring, 2012-2024
18 Europe Blood Glucose Monitoring Market: Revenue in USD million, Rest of Europe, by Segmentation, 2012-2024
19 Europe Blood Glucose Monitoring Market: Revenue in USD million, by Market Indicators, 2012-2024

 

LIST OF FIGURES

1 Europe Blood Glucose Monitoring Market, Revenue in USD million, 2012-2024
2 Europe Countries Diabetes Population 2012-2024
3 Europe Countries with High Obese Population, 2018
4 Europe Blood Glucose Monitoring Market: Revenue Share (%), by Product, Self Blood Glucose Monitor, Global, 2018
5 Europe Blood Glucose Monitoring Market: Revenue Share (%), by Product, CGM, Global, 2018
6 Europe Self Monitoring Blood Glucose Market: Revenue in USD million, by Geography, 2018
7 Europe Blood Glucose Monitoring Market: Revenue in USD million, by SMBG, by Glucometer, 2012-2024
8 Europe Blood Glucose Monitoring Market: Revenue in USD million, by SMBG, by Test Strips, 2012-2024
9 Europe Blood Glucose Monitoring Market: Revenue in USD million, by SMBG, by Lancets, 2012-2024
10 Europe Blood Glucose Monitoring Market: Revenue in USD million, continuous glucose monitor, durable, 2012-2024
11 Europe Blood Glucose Monitoring Market: Revenue in USD million, continuous glucose monitor, Sensor, 2012-2024
12 Europe Blood Glucose Monitoring Market: Revenue in USD million, United Kingdom, 2012-2024
13 Europe Blood Glucose Monitoring Market: Revenue in USD million, Germany, 2012-2024
14 Europe Blood Glucose Monitoring Market: Revenue in USD million, France, 2012-2024
15 Europe Blood Glucose Monitoring Market: Revenue in USD million, Italy, 2012-2024
16 Europe Blood Glucose Monitoring Market: Revenue in USD million, Spain, 2012-2024
17 Europe Blood Glucose Monitoring Market: Revenue in USD million, Russia, 2012-2024
18 Europe Blood Glucose Monitoring Market: Revenue in USD million, Rest of Europe, 2012-2024
19 Abbott Diabetes Care Revenue in USD million, 2016-2018
20 Abbott Diabetes Care Revenue Breakdown -  By Division (2018)
21 Abbott Diabetes Care Revenue Breakdown -  By Geographic Segment (2018)
22 Roche Revenue in USD million, 2016-2018
23 Roche Revenue Breakdown -  By Division (2018)
24 Roche Revenue Breakdown -  By Geographic Segment (2018)
25 Johnson & Johnson Revenue in USD million, 2016-2018
26 Johnson & Johnson Revenue Breakdown -  By Division (2018)
27 Johnson & Johnson Revenue Breakdown -  By Geographic Segment (2018)
28 Dexcom Revenue in USD million, 2016-2018
29 Dexcom Revenue Breakdown -  By Division (2018)
30 Dexcom Revenue Breakdown -  By Geographic Segment (2018)
31 Medtronic Revenue in USD million, 2016-2018
32 Medtronic Revenue Breakdown -  By Division (2018)
33 Medtronic Revenue Breakdown -  By Geographic Segment (2018)
34 Arkray Revenue in USD million, 2016-2018
35 Arkray Revenue Breakdown -  By Division (2018)
36 Arkray Revenue Breakdown -  By Geographic Segment (2018)
37 Ascensia Diabetes Care Revenue in USD million, 2016-2018
38 Ascensia Diabetes Care Revenue Breakdown -  By Division (2018)
39 Ascensia Diabetes Care Revenue Breakdown -  By Geographic Segment (2018)
40 Agamatrix Inc. Revenue in USD million, 2016-2018
41 Agamatrix Inc. Revenue Breakdown -  By Division (2018)
42 Agamatrix Inc. Revenue Breakdown -  By Geographic Segment (2018)
43 Bionime Corporation Revenue in USD million, 2016-2018
44 Bionime Corporation Revenue Breakdown -  By Division (2018)
45 Bionime Corporation Revenue Breakdown -  By Geographic Segment (2018)
46 Acon Revenue in USD million, 2016-2018
47 Acon Revenue Breakdown -  By Division (2018)
48 Acon Revenue Breakdown -  By Geographic Segment (2018)
49 Medisana Revenue in USD million, 2016-2018
50 Medisana Revenue Breakdown -  By Division (2018)
51 Medisana Revenue Breakdown -  By Geographic Segment (2018)
52 Trivida Revenue in USD million, 2016-2018
53 Trivida Revenue Breakdown -  By Division (2018)
54 Trivida Revenue Breakdown -  By Geographic Segment (2018)
55 Rossmax Revenue in USD million, 2016-2018
56 Rossmax Revenue Breakdown -  By Division (2018)
57 Rossmax Revenue Breakdown -  By Geographic Segment (2018)
58 Company Share Analysis (2018)

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Self-monitoring Blood Glucose Devices

        1. 5.1.1.1 By Component (Value and Volume, 2012-2025)

          1. 5.1.1.1.1 Glucometer Devices

          2. 5.1.1.1.2 Test Strips

          3. 5.1.1.1.3 Lancets

      2. 5.1.2 Continuous Glucose Monitoring

        1. 5.1.2.1 By Component (Value and Volume, 2012-2025)

          1. 5.1.2.1.1 Sensors

          2. 5.1.2.1.2 Durables

    2. 5.2 By Geography

      1. 5.2.1 Europe

        1. 5.2.1.1 France (Value and Volume, 2012-2025)

          1. 5.2.1.1.1 Self-monitoring Blood Glucose Devices

            1. 5.2.1.1.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.2.1.1.2 Continuous Glucose Monitoring

            1. 5.2.1.1.2.1 By Component (Sensors and Durables)

        2. 5.2.1.2 Germany (Value and Volume, 2012-2025)

          1. 5.2.1.2.1 Self-monitoring Blood Glucose Devices

            1. 5.2.1.2.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.2.1.2.2 Continuous Glucose Monitoring

            1. 5.2.1.2.2.1 By Component (Sensors and Durables)

        3. 5.2.1.3 Italy (Value and Volume, 2012-2025)

          1. 5.2.1.3.1 Self-monitoring Blood Glucose Devices

            1. 5.2.1.3.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.2.1.3.2 Continuous Glucose Monitoring

            1. 5.2.1.3.2.1 By Component (Sensors and Durables)

        4. 5.2.1.4 Spain (Value and Volume, 2012-2025)

          1. 5.2.1.4.1 Self-monitoring Blood Glucose Devices

            1. 5.2.1.4.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.2.1.4.2 Continuous Glucose Monitoring

            1. 5.2.1.4.2.1 By Component (Sensors and Durables)

        5. 5.2.1.5 United Kingdom (Value and Volume, 2012-2025)

          1. 5.2.1.5.1 Self-monitoring Blood Glucose Devices

            1. 5.2.1.5.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.2.1.5.2 Continuous Glucose Monitoring

            1. 5.2.1.5.2.1 By Component (Sensors and Durables)

        6. 5.2.1.6 Russia (Value and Volume, 2012-2025)

          1. 5.2.1.6.1 Self-monitoring Blood Glucose Devices

            1. 5.2.1.6.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.2.1.6.2 Continuous Glucose Monitoring

            1. 5.2.1.6.2.1 By Component (Sensors and Durables)

        7. 5.2.1.7 Rest of Europe (Value and Volume, 2012-2025)

          1. 5.2.1.7.1 Self-monitoring Blood Glucose Devices

            1. 5.2.1.7.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.2.1.7.2 Continuous Glucose Monitoring

            1. 5.2.1.7.2.1 By Component (Sensors and Durables)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes population (2012-2025)

    2. 6.2 Type-2 Diabetes population (2012-2025)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company Profiles

      1. 7.1.1 Abbott

      2. 7.1.2 F. Hoffmann-La Roche AG

      3. 7.1.3 Johnson & Johnson

      4. 7.1.4 Dexcom

      5. 7.1.5 Medtronic

      6. 7.1.6 Arkray

      7. 7.1.7 Ascensia Diabetes Care

      8. 7.1.8 Agamatrix Inc.

      9. 7.1.9 Bionime Corporation

      10. 7.1.10 Acon

      11. 7.1.11 Medisana

      12. 7.1.12 Trivida

      13. 7.1.13 Rossmax

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Europe Blood Glucose Monitoring Market market is studied from 2018 - 2026.

The Europe Blood Glucose Monitoring Market is growing at a CAGR of >11% over the next 5 years.

Dexcom, Abbott, Johnson & Johnson, Medtronic, F. Hoffmann-La Roche AG are the major companies operating in Europe Blood Glucose Monitoring Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!